Sheba Medical Center, which is located in Ramat Gan, Israel and claims to be the country’s largest medical centre, has announced a major collaboration agreement with Thomas Jefferson University (Philadelphia, USA) to advance neuroscience research and clinical care across the two institutions.
As per this agreement, a “state-of-the-art” joint neuroscience centre will be built on Sheba’s campus in Israel, with its doors set to open in late 2024.
According to a press release, a memorandum of understanding signed between the two institutions at the site of the new facility outlined collaboration in four key areas: academia, innovation, research and clinical care. Focusing on these areas, Sheba and Thomas Jefferson will combine their respective, world-leading neuroscience expertise to develop the “new treatments of tomorrow”, the release adds.
“We share a mutual vision with Thomas Jefferson University that the world must accelerate the transformation of clinical care and forge a bold new path. This agreement is part of that goal,” said Yitshak Kreiss, director of Sheba Medical Center. “Our collaboration in neuroscience will enable both of us to lead the way in development and implementation of cutting-edge, world-changing technology.”
The new neuroscience centre, located in Sheba’s campus outside of Tel Aviv, Israel, will focus on a range of brain diseases including epilepsy, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), movement disorders, stem cell research and behavioural disorders. As well as providing Israeli patients with the most advanced technologies and treatments on offer, it will also act as an academic research hub, becoming Thomas Jefferson University’s permanent office in Israel.
“We at Thomas Jefferson University are delighted to partner with an institution that shares a tradition of making things happen in healthcare. Together, we have the power to move the needle,” said Mark L Tykocinski, president of Thomas Jefferson University. “The new neuroscience centre opens up a world of possibilities for collaboration between us as well as real advances in the field.”
